Antitumor activity, pharmacology, and toxicity of ellipticines, ellipticinium, and 9-hydroxy derivatives: preliminary clinical trials of 2-methyl-9-hydroxy ellipticinium (NSC 264-137).

Source:http://linkedlifedata.com/resource/pubmed/id/7003658

Download in:

View as

General Info

PMID
7003658